Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. (Q30379729)

21 June 2017

Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. (English)

1 reference

21 June 2017

16

Qihan Li

1 reference

21 June 2017

Ying Zhang

1

1 reference

21 June 2017

Lichun Wang

2

1 reference

21 June 2017

Yun Liao

3

1 reference

21 June 2017

Longding Liu

4

1 reference

21 June 2017

Kaili Ma

5

1 reference

21 June 2017

Erxia Yang

6

1 reference

21 June 2017

Jingjing Wang

7

1 reference

21 June 2017

Yanchun Che

8

1 reference

21 June 2017

Li Jiang

9

1 reference

21 June 2017

Jing Pu

10

1 reference

21 June 2017

Lei Guo

11

1 reference

21 June 2017

Min Feng

12

1 reference

21 June 2017

Yan Liang

13

1 reference

21 June 2017

Wei Cui

14

1 reference

21 June 2017

Huai Yang

15

1 reference

21 June 2017

language of work or name

English

0 references

publication date

26 September 2015

1 reference

21 June 2017

1 reference

21 June 2017

33

1 reference

21 June 2017

46

1 reference

21 June 2017

6290-6297

1 reference

The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

An overview of the evolution of enterovirus 71 and its clinical and public health significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Fatal enterovirus 71 encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

An inactivated enterovirus 71 vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Mouse models of human genetic disease: which mouse is more like a man?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Modifier genes in mice and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

The infectious diseases consequences of monkey business

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Study of the integrated immune response induced by an inactivated EV71 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

The gene expression profile of peripheral blood mononuclear cells from EV71-infected rhesus infants and the significance in viral pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Pathogenesis study of enterovirus 71 infection in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Enterovirus 71 outbreak in the People's Republic of China in 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Evolutionary and Biomedical Insights from the Rhesus Macaque Genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Genome sequence and global sequence variation map with 5.5 million SNPs in Chinese rhesus macaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.09.047

10.1016/J.VACCINE.2015.09.047

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference